Willis Johnson & Associates’s Argan AGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-4,000
Closed -$2.18M – 105
2026
Q1
$2.18M Hold
4,000
– – 0.13% 52
2025
Q4
$1.25M Hold
4,000
– – 0.08% 63
2025
Q3
$1.08M Buy
+4,000
New +$917K 0.07% 73

Other funds holding AGX

Willis Johnson & Associates's AGX Position: Q2 2026 in Review

Willis Johnson & Associates sold out of Argan (AGX) in Q2 2026, closing a stake of 4,000 shares — an estimated $2.18M sold.

Willis Johnson & Associates first reported a position in AGX in Q3 2025 and held it in 3 quarters. The position peaked at $2.18M in Q1 2026. 566 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Willis Johnson & Associates reported no remaining Argan position as of Q2 2026 after selling out during the quarter.
  • Willis Johnson & Associates sold 4,000 Argan shares in Q2 2026, an estimated $2.18M.
  • Willis Johnson & Associates first reported a position in Argan in Q3 2025 and held it in 3 quarters.
  • Willis Johnson & Associates's Argan position peaked at $2.18M in Q1 2026.
  • 566 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Willis Johnson & Associates's 13F filing for Q2 2026, filed 13 Aug 2026.